Status:
TERMINATED
Cure Rates of Superficial Basal Cell Carcinoma (BCC) EDC
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
Skin Cancer Foundation
Dermatology Foundation
Conditions:
Superficial Basal Cell Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective, randomized clinical trial conducted at the Unviersity of Wisconsin (UW) Dermatology Clinic located at 1 S. Park Street, Madison, WI 53715. There are no controls. Subjects meetin...
Eligibility Criteria
Inclusion
- Untreated, biopsy proven superficial type basal cell carcinoma (BCC-S) on the trunk and/or extremities
- Age greater than 21
- Women with childbearing potential (including those who are pregnant/lactating)
- Able to provide written informed consent
Exclusion
- Aggressive histology on initial biopsy (i.e. morpheaform, infiltrative, desmoplastic, or purely micronodular)
- Prior history of BCC or other skin cancer at the same location
- Lesion \> 2 cm
- Patients with basal cell nevus syndrome
- Transplant patients
- Immunocompromised patients
- Recurrent BCC
- Greater than 2 BCC-S on the trunk and/or extremities
- Prisoners
- Allergy to lidocaine or epinephrine
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT00994240
Start Date
May 1 2008
End Date
September 1 2013
Last Update
February 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin-Madison, Department of Dermatology
Madison, Wisconsin, United States, 53715